Showing results (171-180 of 875) with videos related to
Sort By:
Pageof 88
Protoplasma|December 23, 2004
Membrane-wall attachments in plasmolysed plant cellsI Lang, D A Barton, R L OverallClinical Pharmacokinetics|July 25, 2014
Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involvedRui Li, Hugh A Barton, Manthena V VarmaCPT: Pharmacometrics & Systems Pharmacology|December 11, 2014
Toward Prospective Prediction of Pharmacokinetics in OATP1B1 Genetic Variant PopulationsR Li, H A Barton, T S MaurerCPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis ConditionsR Li, H A Barton, T S MaurerImaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Organization of distributed cortical connections underlying the processing of auditory information in dogs assessed by diffusion MRIMélina Cordeau, Sophie A Barton, Erin E HechtBMJ Military Health|November 20, 2024
Development of a novel 'In-Water Mass Casualty Triage Tool'Colin A Barton, P Morgan, M J TiptonThe Journal of Comparative Neurology|September 13, 2024
Covariation of Skull and Brain Morphology in Domestic DogsSophie A Barton, Marc Kent, Erin E HechtScientific Reports|January 14, 2021
Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cellsA Casasola-LaMacchia, M S Ritorto, R J Seward, et al.Journal of Viral Hepatitis|January 29, 2008
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV diseaseM R B Hamed, A W Tarr, C P McClure, et al.Environmental Health Perspectives|January 10, 2002
A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessmentHarvey J Clewell, Melvin E Andersen, Hugh A BartonPageof 88